UBS AG Logo
Login | Preferences | Contact |engita
UBS Fund Gate - Luxembourg
   
Home
News
Products
Compare products
Virtual portfolios
E-mail subscription
General information
 
 
Search for products
Overview
Search by criteria
Product information
UBS products  ›  Product information
UBS (Irl) Investor Selection – Equity Opportunity Long Short Fund (EUR) P-PF-acc
ISIN no.:  IE00BSSWB770
PDF
PDF
PDF
Overview  
Category profile
UBS Alternative Funds offer a reduction of portfolio volatility, broad diversification to spread risks and innovative products managed by investment experts.

Fund description
Long short equity strategy seeking to exploit short and mid term stock price anomalies opportunistically in companies globally. Investments are based on fundamental, quantitative and qualitative analysis.
The portfolio manager seeks to generate positive returns with long or short equity exposure on stocks he is either positive or negative on. In addition he aims to generate returns from incorporating his view on market movements and varying net equity market exposure (beta can vary between -0.25 to 0.7).
The fund seeks to generate an annualized ex-ante volatility of less than 10% over a period of a market cycle (3-5 years).
The fund suits experienced investors who want to diversify their portfolio and understand the risks.

Key benefits
An investment strategy that aims to produce returns driven by stock selection while achieving some downside protection in declining equity markets.
The fund is managed in accordance with UCITS rules & guidelines.
The fund offers daily liquidity.
You put your trust in the skills of a portfolio management team with an extensive experience in fundamental research and quantitative as well as qualitative analysis.

Risks
UBS Equity Long-Short Funds deliver a long and short exposure to equities in order to reduce the volatility of the portfolio compared to a common long only equity fund. Despite the expected reduction in volatility, the funds can still be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and risk capacity are required. The fund may enter into OTC derivative contracts to generate the equity exposure. These contracts are collateralised, however the risk of a counterparty default remains. UBS Equity Long-Short Funds pursue an active management style and may deliver significant negative performance over certain periods. The fund can perform negatively while underlying equity markets perform positively and vice versa. Each fund has specific risks, which can significantly increase under unusual market conditions. As the fund uses derivatives & sophisticated leverage techniques, investors must be willing to bear the additional risk involved.

Product features
Product category
UBS Alternative Funds
UBS Long Short Funds
Product domicile
Ireland
Portfolio management
UBS Asset Management
Fund management
UBS Fund Management (Luxembourg) S.A.
Custodian bank
J.P. Morgan Bank (Ireland) Plc
Representative for products established under foreign law
UBS Fund Services (Luxembourg) S.A.
Day of inception
January 27, 2015
Currency of account
EUR
Close of financial year
September 30
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Performance fee
20.00%
Management fee
1.50% p.a.
Total expense ratio (TER)
1.65% p.a.
Swing pricing
yes
Minimum investment
n.a.

Current data
Net asset value
EUR88.45
13/12/2017
High - last 12 months
EUR89.99
21/11/2017
Low - last 12 months
EUR83.22
25/09/2017
Assets of the unit class in mn
EUR30.05
13/12/2017
Total product assets in mn
EUR282.99
13/12/2017

Symbols
ISIN no.
IE00BSSWB770
Bloomberg Ticker
UEOLPFE ID

 
Performance chart (EUR-based, as of December 13, 2017)
Indexed, Month-end values
Performance chart (EUR-based, as of December 13, 2017)

Past performance is not a reliable indicator of future results.

Performance (in %, as of December 13, 2017)
in %
1
year
3
years
5
years
since
27/01/2015
EUR
2.71
-
-
-11.55
The performance shown does not take account of any commissions, entry or exit charges.
These figures refer to the past. Past performance is not a reliable indicator of future results.

10 largest positions long (in %) (in %, as of November 30, 2017)
Facebook
3.00
Reckitt Benckiser
2.30
UnitedHealth
1.90
Anthem
1.90
Honeywell
1.70
Novartis
1.50
Wynn Resorts
1.50
Shop Apotheke
1.50
Deutsche Wohnen
1.50
Boeing
1.40
Additional fees (e.g. entry or exit fees) may be charged by the Distributor. Please refer to your financial adviser for more details. For a definition of financial terms refer to the glossary available at www.ubs.com/glossary.
For marketing and information purposes by UBS. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS Fund Services (Luxembourg) S.A., P.O. Box 91, L-2010 Luxembourg or from UBS Europe SE, Luxembourg Branch, P.O. Box 2, L-2010 Luxembourg. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management
Source for all data and charts (if not indicated otherwise): UBS Asset Management
No responsibility is taken for the correctness of the information provided above.

Important legal information - please read the disclaimer before proceeding.
Products and services in these web pages may not be available for residents of certain nations.
Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2017. All rights reserved.
Privacy Policy